公司股价表现 - Modular Medical Inc (MODD) 股价在盘后交易中大幅上涨30.68%至0.9150美元 此前在常规交易时段微涨1.27%至0.7002美元[1] - Galectin Therapeutics Inc (GALT) 股价盘后上涨超过14%至6.78美元 年初至今累计涨幅超过360% 并在2025年9月11日创下52周新高5.99美元[3] - Exicure Inc (XCUR) 股价盘后上涨11.11%至4.00美元 尽管没有公司特定消息推动[5] - PepGen Inc (PEPG) 股价盘后反弹6.67%至1.44美元 此前在常规交易时段下跌3.57%至1.35美元[6] - BioSig Technologies Inc (BSGM) 股价在常规交易时段大涨37.08%至6.10美元 盘后续涨4.09%至6.35美元[8] 临床进展与产品开发 - Modular Medical完成MODD1胰岛素泵临床研究 预计2025年10月向FDA提交Pivot泵产品申请[1] - Galectin Therapeutics正在分析额外生物标志物 预计年底前公布其主导候选药物belapectin (GR-MD-02)的研究结果[4] - Galectin Therapeutics的NAVIGATE试验数据显示治疗患者新发食管静脉曲张减少[5] - Exicure完成GPC-100治疗多发性骨髓瘤患者干细胞动员的二期研究[6] - PepGen将重点完全转向PGN-EDODM1 用于治疗1型强直性肌营养不良症 该药物在早期研究中显示良好的剪接校正效果[7] - PepGen的FREEDOM-DM1试验正在进行中 预计2025年第四季度初公布15 mg/kg队列的顶线数据[7] 财务与运营状况 - Exicure第二季度净亏损260万美元 较2024年同期的60万美元亏损大幅扩大 主要由于2025年初收购GPCR USA后运营费用增加[6] - Modular Medical内部人士购买超过50万美元公司股票[2] - Modular Medical交易量激增至超过450万股 远高于约20万股的平均水平[2] 战略转型与公司行动 - Exicure通过收购GPCR USA实现战略转型 从核酸疗法转向新的临床方向[6] - PepGen在CONNECT1试验未达到疗效目标后 停止了杜氏肌营养不良症(DMD)项目PGN-EDO51的开发[7] - BioSig Technologies正式更名为Streamex Corp 并于2025年9月12日起在纳斯达克资本市场以新代码"STEX"交易[8] - BioSig与Streamex Exchange Corp合并 从医疗器械领域战略转型至现实世界资产代币化[9] - Streamex与Monetary Metals建立独家合作伙伴关系 开发代币化生息黄金产品[9] 产品与市场定位 - Modular Medical的MODD1胰岛素泵旨在简化糖尿病管理[1] - Galectin Therapeutics的belapectin是一种新型半乳糖凝集素-3抑制剂 获得快速通道指定 用于治疗MASH肝硬化和门静脉高压 该公司是该领域唯一专注的企业[4]

As filed with the Securities and Exchange Commission on May 12, 2023 Registration No. 333-271413 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 2 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) | Nevada | | --- | (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 3841 87-0620495 (I.R.S. Employer Ide ...

As filed with the Securities and Exchange Commission on May 5, 2023 Registration No. 333-271413 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 AMENDMENT NO. 1 TO FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 3841 87-0620495 (I.R.S. Employer Identification Number) ...

As filed with the Securities and Exchange Commission on April 24, 2023 Registration No. 333-[●] UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 MODULAR MEDICAL, INC. (Exact name of registrant as specified in its charter) (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) Nevada 3841 87-0620495 (I.R.S. Employer Identification Number) 10740 Thornmint Dri ...